ACTELION PHARMACEUTICALS US, INC.
Corporation · Wilmington, United States · LEI 549300S4OAK6AYWHL542
LEI lapsed
Summary
ACTELION PHARMACEUTICALS US, INC. is registered in the United States. Its legal form is Corporation. According to GLEIF, its ultimate parent is Johnson & Johnson (United States), which is also its direct parent. That group has 209 subsidiaries with LEIs in 47 countries, 55 of them in the United States. The LEI was first issued on 10 Aug 2017 and the record was last updated on 22 Sep 2025. It has lapsed: renewal was due by 22 Sep 2025. AssetCensus found 2 data-quality notes for this entity (see below).
Written from GLEIF data using fixed, reviewed sentence templates.
Data-quality notes (AssetCensus analysis)
- The LEI has lapsed: it was due for renewal by 22 Sep 2025 and was not renewed, so GLEIF's data for this entity has not been re-verified since. A lapsed LEI does not mean the company has ceased to exist.
- The ultimate-parent relationship record was not renewed; it was last updated on 22 Sep 2025.
Company details
| Legal form | Corporation |
|---|---|
| Register | · Register website |
| Registration number | 2902350 |
| Registration authority | Division of Corporations, Department of State |
| Jurisdiction | United States (US-DE) |
| Registered address | c/o The Corporation Trust Company, Corporation Trust Center, 19801 Wilmington, United States |
| Headquarters address | 1125 Trenton-Harbourton Road, 08560 Titusville, United States |
| Category | company or other legal entity |
| Status | active |
| Founded (per GLEIF) | 29 May 1998 |
| LEI | 549300S4OAK6AYWHL542 |
| LEI status | lapsed |
| LEI first issued | 10 Aug 2017 |
| LEI record last updated | 22 Sep 2025 |
| Next LEI renewal | 22 Sep 2025 |
| Corroboration of the LEI record | fully corroborated |
Group membership
ACTELION PHARMACEUTICALS US, INC. this entity
Relationship to the parent
| Direct parent | Ultimate parent | |
|---|---|---|
| Parent | Johnson & Johnson | Johnson & Johnson |
| Accounting period | 1 Jan 2024 to 31 Dec 2024 | 1 Jan 2024 to 31 Dec 2024 |
| Evidence | other official documents | other official documents |
| Corroboration | supplied by the entity only | supplied by the entity only |
| Relationship start | 29 May 1998 | 29 May 1998 |
| Recorded at GLEIF since | 30 May 2024 | 30 May 2024 |
| Last updated | 22 Sep 2025 | 22 Sep 2025 |
| Record status | not renewed | not renewed |
Other subsidiaries of the same direct parent (97)
- ACCLARENT, INC. United States
- ALZA CORPORATION United States
- AMO HOLDINGS, INC. United States lapsed
- AMO SALES AND SERVICE, INC. United States
- AURIS HEALTH, INC. United States
- BIOMEDICAL ENTERPRISES, INC. United States lapsed
- BIOSENSE WEBSTER, INC. United States
- CORDIS FINANCING CORPORATION United States lapsed
- DEPUY SYNTHES PRODUCTS, INC. United States
- DEPUY SYNTHES SALES, INC. United States
- DEPUY SYNTHES, INC. United States
- ETHICON ENDO-SURGERY, INC. United States
History
30 Jul 2023Headquarters address changed